198 related articles for article (PubMed ID: 7512180)
1. Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line.
Kanakura Y; Furitsu T; Tsujimura T; Butterfield JH; Ashman LK; Ikeda H; Kitayama H; Kanayama Y; Matsuzawa Y; Kitamura Y
Leukemia; 1994 Apr; 8 Suppl 1():S18-22. PubMed ID: 7512180
[TBL] [Abstract][Full Text] [Related]
2. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
3. Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3.
Tsujimura T; Furitsu T; Morimoto M; Kanayama Y; Nomura S; Matsuzawa Y; Kitamura Y; Kanakura Y
Int Arch Allergy Immunol; 1995 Apr; 106(4):377-85. PubMed ID: 7536501
[TBL] [Abstract][Full Text] [Related]
4. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation.
Tsujimura T; Furitsu T; Morimoto M; Isozaki K; Nomura S; Matsuzawa Y; Kitamura Y; Kanakura Y
Blood; 1994 May; 83(9):2619-26. PubMed ID: 7513208
[TBL] [Abstract][Full Text] [Related]
5. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.
Kitayama H; Kanakura Y; Furitsu T; Tsujimura T; Oritani K; Ikeda H; Sugahara H; Mitsui H; Kanayama Y; Kitamura Y
Blood; 1995 Feb; 85(3):790-8. PubMed ID: 7530509
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
Ogawa K; Tashima M; Toi T; Sawai H; Sawada H; Fujita J; Maruyama Y; Okuma M
Exp Hematol; 1994 Jan; 22(1):45-51. PubMed ID: 7506674
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of constitutive activation of c-kit receptor tyrosine kinase.
Tsujimura T; Kanakura Y; Kitamura Y
Leukemia; 1997 Apr; 11 Suppl 3():396-8. PubMed ID: 9209403
[TBL] [Abstract][Full Text] [Related]
8. Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene.
Sundström M; Vliagoftis H; Karlberg P; Butterfield JH; Nilsson K; Metcalfe DD; Nilsson G
Immunology; 2003 Jan; 108(1):89-97. PubMed ID: 12519307
[TBL] [Abstract][Full Text] [Related]
9. The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis.
Besmer P; Manova K; Duttlinger R; Huang EJ; Packer A; Gyssler C; Bachvarova RF
Dev Suppl; 1993; ():125-37. PubMed ID: 7519481
[TBL] [Abstract][Full Text] [Related]
10. The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes.
deCastro CM; Denning SM; Langdon S; Vandenbark GR; Kurtzberg J; Scearce R; Haynes BF; Kaufman RE
Exp Hematol; 1994 Sep; 22(10):1025-33. PubMed ID: 7522182
[TBL] [Abstract][Full Text] [Related]
11. Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spots.
Bowen DT; Padua RA; Burnett AK; deCastro CM; Kaufman RE
Leukemia; 1993 Nov; 7(11):1883-5. PubMed ID: 7694008
[TBL] [Abstract][Full Text] [Related]
12. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
Beghini A; Cairoli R; Morra E; Larizza L
Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of c-kit receptor and its ligand in increase of mast cells in neurofibroma tissues.
Hirota S; Nomura S; Asada H; Ito A; Morii E; Kitamura Y
Arch Pathol Lab Med; 1993 Oct; 117(10):996-9. PubMed ID: 7692836
[TBL] [Abstract][Full Text] [Related]
14. c-KIT expression enhances the leukemogenic potential of 32D cells.
Hu Q; Trevisan M; Xu Y; Dong W; Berger SA; Lyman SD; Minden MD
J Clin Invest; 1995 Jun; 95(6):2530-8. PubMed ID: 7539453
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
Shivakrupa R; Bernstein A; Watring N; Linnekin D
Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
[TBL] [Abstract][Full Text] [Related]
16. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat.
Fujio K; Evarts RP; Hu Z; Marsden ER; Thorgeirsson SS
Lab Invest; 1994 Apr; 70(4):511-6. PubMed ID: 7513770
[TBL] [Abstract][Full Text] [Related]
17. Wn mutation of c-kit receptor affects its post-translational processing and extracellular expression.
Koshimizu U; Tsujimura T; Isozaki K; Nomura S; Furitsu T; Kanakura Y; Kitamura Y; Nishimune Y
Oncogene; 1994 Jan; 9(1):157-62. PubMed ID: 7508100
[TBL] [Abstract][Full Text] [Related]
18. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells.
Tsai M; Chen RH; Tam SY; Blenis J; Galli SJ
Eur J Immunol; 1993 Dec; 23(12):3286-91. PubMed ID: 7504992
[TBL] [Abstract][Full Text] [Related]
19. Cell type-specific deficiency of c-kit gene expression in mutant mice of mi/mi genotype.
Isozaki K; Tsujimura T; Nomura S; Morii E; Koshimizu U; Nishimune Y; Kitamura Y
Am J Pathol; 1994 Oct; 145(4):827-36. PubMed ID: 7524330
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macrophage colony-stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase.
Miyazawa K; Hendrie PC; Mantel C; Wood K; Ashman LK; Broxmeyer HE
Exp Hematol; 1991 Dec; 19(11):1110-23. PubMed ID: 1721591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
